At what point can information generated from the P1a/b be used as a reference for the structure of the P2 trial? If interim results show the optimal dose has been achieved can a P2 start earlier or do you need a complete dataset from the P1a/b?
RAC media coverage, page-2201
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.85 |
Change
-0.025(1.33%) |
Mkt cap ! $319.4M | |||
| Open | High | Low | Value | Volume |
| $1.88 | $1.88 | $1.85 | $40.79K | 21.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 843 | $1.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.86 | 356 | 1 |
View Market Depth
| Last trade - 10.40am 18/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |